Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis

NCT05588843 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05588843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05588843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 25, 2022
Completion date
December 2, 2026
Enrollment
187 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

colitis ulcerative